The aim of this study was to examine whether inhibition of type-2A phosphatases would promote degradation of cyclin D1 levels in human breast cancer cells, exposing a mechanism by which small molecule inhibitors may aid in suppression of tumor cell proliferation. This evidence concerns the gene CCND1 and breast cancer.